HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancerYirui Zhai, Lühua Wang, Zhouguang Hui et al.|Radiotherapy and Oncology|2018Cited by 37